SCHEMBL5360628

SCHEMBL5360628

CCCCCCCNC(=O)N(C)c1cccc(-c2ccc(Nc3ccccc3-c3nnc(CCC)o3)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDX3X O00571 1/20 0.40
LTB4R2 Q9NPC1 1/20 0.35
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
ALDH1A1 P00352 4/20 0.34
KDM4E B2RXH2 3/20 0.34
HPGD P15428 3/20 0.34
MAPK14 Q16539 1/20 0.34
MAPT P10636 3/20 0.33
HTT P42858 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
MAPK1 P28482 1/20 0.33
USP2 O75604 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TSHR P16473 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5355409 0.81 LTB4R2 (0.35) LTB4R2ALDH1A1NPC1RAB9AADRB2
SCHEMBL5360965 0.81 LTB4R2 (0.44) LTB4R2HPGDPTGS2
SCHEMBL5355393 0.80 LTB4R2 (0.45) LTB4R2KMT2AMEN1KDM4EHPGD
SCHEMBL5359232 0.80 MEN1 (0.45) DDX3XKMT2AMEN1ALDH1A1KDM4E
SCHEMBL5374059 0.78 PTGS2 (0.41) LTB4R2L3MBTL1PTGS2
SCHEMBL5365094 0.78 SIRT2 (0.46) LTB4R2ALDH1A1HTTPTGS2
SCHEMBL5361591 0.77 SIRT2 (0.41) LTB4R2PTGS2
SCHEMBL3210607 0.76 NAAA (0.49) ALDH1A1HTTNPC1RAB9APTGS2
SCHEMBL3952566 0.76 ADRB2 (0.35) LTB4R2KMT2AMEN1ALDH1A1KDM4E
SCHEMBL2852203 0.75 PPARG (0.41) LTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7307078-B2 Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof GALDERMA RESEARCH & DEVELOPMENT (FR) 2007-12-11 US claimed
EP-1572629-A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS Galderma Research & Development, S.N.C. (FR) 2005-09-14 EP claimed
WO-2004052840-A1 COMPOUNDS WHICH MODULATE PPARϜ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2004-06-24 WO claimed